Joint Position Paper on the Hospital Exemption Scheme for ATMPs

In the context of the revision of the EU General Pharmaceutical Legislation, this paper puts forward joint recommendations from ARM (Alliance for Regenerative Medicine), EFPIA, EuropaBio, EUCOPE (European Confederation of Pharmaceutical Entrepreneurs) and ISCT (International Society for Cell & Gene Therapy), for the reform of the Hospital Exemption (HE) scheme for Advanced Therapy Medicinal Products (ATMPs).

Read more here.